Australia, Feb. 25 -- Zymeworks BC Inc., owns the trademark (2506247) for 'ZYMEWORKS' and 'MOLECULAR-DIAGRAM' till Oct. 15, 2034.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations; medicines for human purposes; diagnostic preparations for medical purposes; chemical preparations for pharmaceutical and medical purposes; biological preparations for medical purposes; therapeutic preparations, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases.], 42 [Chemical, biochemical and biological research and analysis; biotechnological research and development; medical and pharmacological research and development services; pharmaceutical product development and evaluation; conducting clinical trials for pharmaceutical products; scientific research and development of preparations, agents and technology for the development of antibody therapeutics for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, auto immune diseases, inflammatory diseases, and infectious diseases; chemical molecular analysis and product optimization services provided to pharmaceutical, biotechnology and chemical industries using proprietary software and proprietary analytical tools and algorithms.] and 45 [Intellectual property licensing services.]
Type of Mark: Figurative
Date of Acceptance: Dec. 16, 2024
Registration Advertised: Feb. 24
For further details contact GOWLING WLG (CANADA) LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2506247.
Disclaimer: Curated by HT Syndication.
